Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/13/2025

Safe Use of Azithromycin with Levetiracetam

Clinical Guidance for Seizure Management

  • The American Academy of Neurology and European guidelines recommend continuing levetiracetam at the current dose without adjustment when starting azithromycin, as no dose modifications are required, and monitoring for seizure control as you normally would, but do not attribute any breakthrough seizures to drug interaction—instead investigate other precipitating factors such as infection, fever, sleep deprivation, or medication non-compliance 1
  • The European guidelines specifically recommend non-enzyme-inducing anticonvulsants like levetiracetam to avoid impacting metabolism of other medications including antibiotics and steroids, and ensuring the patient maintains therapeutic levetiracetam levels by verifying medication compliance, as non-compliance is a more common cause of breakthrough seizures than drug interactions 2, 3

Avoiding Common Pitfalls

  • The American College of Clinical Pharmacology advises against discontinuing or reducing levetiracetam when starting azithromycin—this is unnecessary and may precipitate withdrawal seizures, and if breakthrough seizures occur during azithromycin treatment, investigate the underlying infection or fever as the seizure trigger rather than assuming a drug interaction 1, 2

REFERENCES

1

Status Epilepticus Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2

Approach to Changing Anti-Seizure Medication for Patients Who Don't Tolerate Levetiracetam [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025